Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity

Basic and Clinical Pharmacology and Toxicology

Volumn 97, Issue 5, 2005, Pages 325-332

  Celik, Ilhami ^a,b   Cihangiroglu, Mustafa ^a   Ilhan, Nevin ^a   Akpolat, Nusret ^a   Akbulut, H Handan ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b Cardiovascular Surgery   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE; ANTIOXIDANT; CREATININE; GINKGO BILOBA EXTRACT; GLUTATHIONE PEROXIDASE; INOTROPIC AGENT; MALONALDEHYDE; MELATONIN; OXYGEN RADICAL; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TEBOKAN; THIOCTIC ACID; UREA; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; KIDNEY FUNCTION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; UREA BLOOD LEVEL;

AMRINONE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; FEMALE; FREE RADICALS; GINKGO BILOBA; GLUTATHIONE PEROXIDASE; KIDNEY CORTEX; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALONDIALDEHYDE; MELATONIN; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THIOCTIC ACID; VANCOMYCIN;

ANIMALIA; GINKGO BILOBA;

EID: 27744497015     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto_153.x     Document Type: Article

References (51)

1. Agapito, M. T., Y. Antolin, M. T. del Brio, S. Lopez-Burillo, M. I. Pablos & J. M. Recio: Protective effect of melatonin against adriamycin toxicity in the rat. J. Pineal. Res. 2001, 31, 23-30.
2. Aranoff, G. R., R. S. Sloan, C. B. Dinwiddie, M. D. Glant, N. S. Fineberg & F. C. Lugt: Effects of vancomycin on renal function in rats. Antimicrob. Agents Chemother. 1981, 19, 306-7308.
3. Baliga, R., N. Ueda, P. D. Walker & S. V. Shah: Oxidant mechanisms in toxic acute renal failure. Drug Metab. Rev. 1999, 31, 971-997.
4. Catherwood, M. A., L. A. Powell, P. Anderson, D. McMaster, P. C. Sharpe & E. R. Trimble: Glucose-induced oxidative stress in mesangial cells. Kidney Int. 2002, 61, 599-608.
5. Cunha, B. A.: Vancomycin. Med. Clin. N. Am. 1995, 79, 817-831.
6. Diplock, A. T.: Antioxidants and free radical scavengers. In: Eds.: C. A. Rice-Evans & R. H. Burdon. Free radical damage and its control. Elsevier Science, Amsterdam, Netherlands, 1994.
7. Downs, N. J., R. E. Neihart, J. M. Dolezal & G. R. Hodges: Mild nephrotoxicity associated with vancomycin use. Arch. Int. Med. 1989, 149, 1777-1781.
8. Dziegiel, P., E. Suder, P. Surowiak, Z. Jethon, J. Rabczynski, L. Januszewska, M. Sopel & M. Zabel: Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat. J. Pineal. Res. 2002, 33, 95-100.
9. Farber, B. F. & R. C. Moellering: Retrospective study of the toxicity of preparations of vancomycin from 1974-1981. Antimicrob. Agents Chemother. 1983, 23, 138-141.
10. Fukaya, H. & H. Kanno: Experimental studies of the protective effect of ginkgo biloba extract (Ginko biloba extract) on cisplatin-induced toxicity in rats. Nippon Jibiinkoka Gakkai Kaiho. 1999, 102, 907-917.
11. Houghton, C. D., C. E. Plamp, J. M. Defehr, W. M. Bennett, G. Forter & D. Gilbert: Gentamicin and tobramycin nephrotoxicity: A morphologic and functional comparison in the rat. Amer. J. Pathol. 1978, 93, 137-152.
12. Jackson, E. K., Z. Mi, J. A. Carcillo, D. G. Gillespie & R. K. Dubey: Phosphodiesterases in the rat renal vasculature. J. Cardiovasc. Pharmacol. 1997, 30, 798-801.
13. Jurasinski, C. V., L. Kilpatrick & T. C. Vary: Amrinone prevents muscle protein wasting during chronic sepsis. Amer. J. Physiol. 1995, 268, E491-500.
14. Karabulut, R., K. Sonmez, B. Sancak, Z. Turkyilmaz, B. Demirogullari, I. O. Ozen, G. Ekingen, S. Candan, A. C. Basaklar & N. Kale: Effects of amrinone on bilateral renal ischemia/reperfusion injury. Urol. Res. 2002, 30, 164-168.
15. Kovacic, R., A. Sacman & M. Wu-Weis: Nephrotoxins: widespread role of oxidative stress and electron transfer. Curr. Med. Chem. 2002, 9, 823-847.
16. Kumar, K. V., M. U. Naidu, A. A. Shifow, A. Prayag & K. S. Ratnakar: Melatonin: An antioxidant protects against cyclosporine-induced nephrotoxicity. Transplantation 1999, 67, 1065-1068.
17. Lowry, O. H., N. J. Rosebrough, A. L. Farr & R. J. Randall: Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
18. Maitra, I., L. Marcocci, M. T. Droy-Lefaix & L. Packer: Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem. Pharmacol. 1995, 49, 1649-1655.
19. Marcocci, L., L. Packer, M. T. Droy-Lefaix, A. Sekaki & M. Gardes-Albert: Antioxidant action of Ginkgo biloba extract EGb 761. Meth. Enzymol. 1994, 234, 462-475.
20. Murugavel, P. & L. Pari: Attenuation of chloroquine-induced renal damage by alpha-lipoic acid: possible antioxidant mechanism. Ren. Fail. 2004, 26, 517-524.
21. Naidu, M. U., A. A. Shifow, K. V. Kumar & K. S. Ratnakar: Ginkgo biloba extract ameliorates gentamicin-induced nephrotoxicity in rats. Phytomedicine 2000, 7, 191-197.
22. Nielsen, F., B. B. Mikkelsen, J. B. Nielsen, H. R. Andersen & P. Grandjean: Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin. Chem. 1997, 47, 1209-1214.
23. Nishino, Y., S. Takemura, Y. Minamiyama, K. Hirohashi, H. Tanaka, M. Inoue, S. Okada & H. Kinoshita: Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat. Redox Rep. 2002, 7, 317-319.
24. Oyama, Y., L. Chikahisa, T. Ueha, K. Kanemaru & K. Noda: Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res. 1996, 712, 349-352.
25. Ozbek, E., Y. Turkoz, E. Sahna, F. Ozugurlu, B. Mizrak & M. Ozbek: Melatonin administration prevents the nephrotoxicity induced by gentamicin. BJU Int. 2000, 85, 742-746.
26. Paglia, D. E. & W. N. Valentina: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70, 158-169.
27. Paller, M. S., J. R. Hoidal & T. F. Ferris: Oxygen free radicals in ischemic renal failure in the rats. J. Clin. Invest. 1984, 74, 1156-1164.
28. Parlakpinar, H., M. K. Ozer, E. Sahna, N. Vardi, Y. Cigremis & A. Acet: Amikacin-induced acute renal injury in rats: protective role of melatonin. J. Pineal Res. 2003, 35, 85-90.
29. Parlakpinar, H., E. Sahna, M. K. Ozer, F. Ozugurlu, N. Vardi & A. Acet: Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury. J. Pineal Res. 2002, 33, 161-166.
30. Ramassamy, C., F. Girbe, J. Pincemail, Y. Christen & J. Costentin: Modifications of the synaptosomal dopamine uptake and release by two systems generating free radicals: ascorbic acid/Fe2+ and L-arginine/NADPH. Ann. N. Y. Acad. Sci. 1994, 738, 141-152.
31. Raner, C. B., J. Biber, J. Martner & O. Winso: Interactive effects of isoflurane and amrinone in the feline intestinal and renal circulation. Acta anaesth. scand. 1991, 35, 196-200.
32. Salama, S. E. & C. Rotstein: Prospective assessment of nephrotoxicity with concomitant aminoglycoside and vancomycin therapy. Can. J. Hosp. Pharm. 1993, 46, 53-59.
33. Sandhya, P., S. Mohandass & P. Varalakshmi: Role of DL alpha-lipoic acid in gentamicin induced nephrotoxicity. Mol. Cell. Biochem. 1995, 145, 11-17.
34. Sandhya, P. & P., Varalakshmi: Effect of lipoic acid administration on gentamicin-induced lipid peroxidation in rats. J. Appl. Toxicol. 1997, 17, 405-408.
35. Satoh, K.: Serum Lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin. Chim. Acta 1978, 90, 37-43.
36. Sener, G., A. O., Sehirli, M. Keyer-Uysal, S. Arbak, Y. Ersoy & B. C. Yegen: The protective effect of melatonin on renal ischemia-reperfusion injury in the rat. J. Pineal Res. 2002a, 32, 120-126.
37. Sener, G., A. O. Sehirli, H. Z. Altunbas, Y. Ersoy, K. Paskaloglu, S. Arbak & G. Ayanoglu-Dulger: Melatonin protects against gentamicin-induced nephrotoxicity in rats. J. Pineal Res. 2002b, 32, 231-236.
38. Sener, G., A. O. Sehirli, H. Satiroglu, M. Keyer-Uysal & B. C. Yegen: Melatonin prevents oxidative kidney damage in a rat model of thermal injury. Life Sci. 2002c, 70, 2977-2985.
39. Setoyama, K., H. Ota, N. Miura, M. Fujiki, K. Misumi & H. Sakamoto: Effects of milrinone on hemodynamics and regional blood flow in the hypoxic dog. J. Vet. Med. Sci. 2002, 64, 499-503.
40. Shifow, A. A., K. V. Kumar, M. U. Naidu & K. S. Ratnakar: Melatonin, a pineal hormone with antioxidant property, protects against gentamicin-induced nephrotoxicity in rats. Nephron 2000, 85, 167-174.
41. Somani, S. M., K. Husain, C. Whitworth, G. L. Trammell, M. Malafa & L. P. Rybak: Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: Antioxidant defense system. Pharmacology & Toxicology 2000, 86, 234-241.
42. Stacchiotti, A., A. Lavazza, R. Rezzani & R. Bianchi: Cyclosporine A-induced kidney alterations are limited by melatonin in rats: An electron microscope study. Ultrastruct. Pathol. 2002, 26, 81-87.
43. Sun, Y., L. W. Oberley & Y. Li: A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988, 34, 497-500.
44. Takaoka, M., M. Ohkita, Y. Kobayashi, M. Yuba & Y. Matsumura: Protective effect of alphalipoic acid against ischaemic acute renal failure in rats. Clin. Exp. Pharmacol. Physiol. 2002, 29, 189-194.
45. Tobin, C. M., J. M. Darville, A. H. Thomson, G. Sweeney, J. F. Wilson, A. P. MacGowan & L. O. White: Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire. J. Antimicrob. Chemother. 2002, 50, 713-718.
46. Tylicki, L., B. Rutkowski & W. H. Horl: Antioxidants: A Possible Role in Kidney Protection. Kidney Blood Press Res. 2003, 26, 303-314.
47. Varalakshmi, P., S. Sandhya & K. P. Malarkodi: Evaluation of the effect of lipoic acid administered along with gentamicin in rats rendered bacteremic. Mol. Cell. Biochem. 2003, 248, 35-40.
48. Wold, J. S. & S. A. Turnipseed: Toxicology of vancomycin in laboratory animals. Rev. Infect. Dis. 1981, 3, 224-229.
49. Wood, C. A., S. J. Kohlhepp, P. W. Rohnen, D. C. Houghton & D. N. Gilbert: Vancomycin enhancement of experimental tobramycin nephrotoxicity. Antimicrob. Agents Chemother. 1986, 30, 20-24.
50. Yagi, K.: Assay of blood plasma or serum. Meth. Enzymol. 1984, 105, 328-331.
51. Young, I. S. & I. S. Woodside: Antioxidants in health and disease. J. Clin. Pathol. 2001, 54, 176-186.